VNDRIQ — Vendor Comparison
DeepHealth vs Annalise.ai
Side-by-side comparison of BAA status, PHI exposure, AI training risk, HIPAA suitability, and VNDRIQ governance scores.
DeepHealth
Medical Imaging AI
Last verified: August 31, 2026
Annalise.ai
Medical Imaging AI
Verification pending
VNDRIQ Scores
70
Overall
82
Overall
Approval Tier
BAA Status
PHI Exposure Risk
AI Training Risk
HIPAA Risk Level
Review Frequency
Quarterly
Quarterly
Recommended Use
Radiology workflow automation, breast cancer screening, prostate lesion detection, and clinical decision support.
Radiology triage and notification for critical findings on chest X-rays and head CT scans to optimize clinical workflow.
Restrictions
Use is subject to specific FDA-cleared indications for each module.
Indicated for patients 22 years and older; specific to cleared findings such as pneumothorax, tension pneumothorax, and obstructive hydrocephalus.
Executive Summary
DeepHealth
Medical Imaging AI
DeepHealth is classified as Approved with a BAA status of Available for enterprise customers. PHI exposure is rated Medium and AI training risk is Medium. Radiology workflow automation, breast cancer screening, prostate lesion detection, and clinical decision support.
61
Privacy
85
Governance
69
Healthcare
65
AI Risk
Annalise.ai
Medical Imaging AI
Annalise.ai is classified as Approved with a BAA status of Available for clinical deployments in the United States; required for partnerships with US health systems like Mass General Brigham.. PHI exposure is rated Low and AI training risk is Medium. Radiology triage and notification for critical findings on chest X-rays and head CT scans to optimize clinical workflow.
85
Privacy
85
Governance
83
Healthcare
76
AI Risk
Recommended For
DeepHealth
Radiology workflow automation, breast cancer screening, prostate lesion detection, and clinical decision support.
Organizations with established governance workflows
Multi-location healthcare groups needing standardized vendor status
Annalise.ai
Radiology triage and notification for critical findings on chest X-rays and head CT scans to optimize clinical workflow.
Organizations with established governance workflows
Multi-location healthcare groups needing standardized vendor status
Governance Considerations
DeepHealth
Quarterly reviews are required — establish internal review cadence.
Restrictions noted: Use is subject to specific FDA-cleared indications for each module.
Annalise.ai
Quarterly reviews are required — establish internal review cadence.
Restrictions noted: Indicated for patients 22 years and older; specific to cleared findings such as pneumothorax, tension pneumothorax, and obstructive hydrocephalus.
Questions to Ask Before Approval
Has the vendor executed a Business Associate Agreement (BAA) with your organization?
Does the vendor use customer data to train AI models? Can you opt out?
Where is PHI stored, processed, and transmitted?
What data retention and deletion policies apply to your PHI?
Has the vendor undergone a third-party HIPAA or SOC 2 audit?
What is the vendor's incident response and breach notification process?
Does the vendor offer audit logging for PHI access?
What subprocessors have access to PHI through this vendor?
Request Vendor Evaluation
Get a structured risk assessment for any vendor.
Request Benchmark Report
Compare vendors across your full stack.
Book Governance Assessment
Talk to a VNDRIQ governance specialist.